International Clinical Trial: Evaluate the safety and immunogenicity of the adsorbed tetanus vaccine in participants aged >=18 years: a randomized, double-blind, parallel-controlled phase I clinical trial with a similar type of vaccine as the active comparator

Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134601) titled 'Evaluate the safety and immunogenicity of the adsorbed tetanus vaccine in participants aged >=18 years: a randomized, double-blind, parallel-controlled phase I clinical trial with a similar type of vaccine as the active comparator' on Oct. 16.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Hubei Provincial Center for Disease Control and Prevention

Condition: Tetanus

Intervention: Control group:Receive the vaccine(Chengdu Oulin Biotechnology Co., Ltd.)

Recruitment Status: Not Recruiting

Phase: 1

Date of First Enrollment: 2026-05-21

Target Sample Size: Control group:40;Experi...